ClinicalTrials.Veeva

Menu
C

Clinical Research Centre | Tartu, Estonia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Apremilast
Filgotinib
Rocatinlimab
Denosumab
Guselkumab
MSB11022
AMG 451
Tezepelumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 18 total trials

A Study Evaluating the Effect of Filgotinib in Participants with Active Axial Spondyloarthritis (OLINGUITO)

This study is comparing 200 milligrams (mg) of filgotinib a day with a placebo to see if filgotinib helps to treat Axial Spondyloarthritis (axSpA) an...

Active, not recruiting
Axial Spondyloarthritis
Drug: Placebo
Drug: Filgotinib

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety an...

Active, not recruiting
Cytomegalovirus Infection
Biological: mRNA-1647
Biological: Placebo

This is a Phase 3, randomized, parallel-group, comparator-controlled, observer-blind, multicenter study of immunogenicity and safety in approximately...

Active, not recruiting
Influenza, Human
Biological: licensed QIV2
Biological: Investigational aQIVc

Trial sponsors

Amgen logo
Celltrion Healthcare logo
G
Fresenius Kabi logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
Moderna logo
Pfizer logo
Seqirus logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems